Cargo Therapeutics Q2 2024 Adj EPS $(1.02) Beats $(1.03) Estimate
Portfolio Pulse from Benzinga Newsdesk
Cargo Therapeutics (NASDAQ:CRGX) reported a Q2 2024 adjusted EPS of $(1.02), which beat the analyst consensus estimate of $(1.03) by 0.97%.
August 12, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cargo Therapeutics reported a Q2 2024 adjusted EPS of $(1.02), beating the analyst consensus estimate of $(1.03) by 0.97%.
The company's adjusted EPS beat the analyst consensus estimate, which is generally viewed positively by investors. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100